Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Medicinova Inc (MNOV)

Medicinova Inc (MNOV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 106,430
  • Shares Outstanding, K 49,046
  • Annual Sales, $ 1,000 K
  • Annual Income, $ -8,570 K
  • EBIT $ -12 M
  • EBITDA $ -12 M
  • 60-Month Beta 0.84
  • Price/Sales 105.94
  • Price/Cash Flow N/A
  • Price/Book 1.92

Options Overview Details

View History
  • Implied Volatility 166.36% ( +77.86%)
  • Historical Volatility 135.64%
  • IV Percentile 43%
  • IV Rank 24.38%
  • IV High 619.24% on 06/04/24
  • IV Low 20.38% on 10/15/24
  • Put/Call Vol Ratio 0.00
  • Today's Volume 9
  • Volume Avg (30-Day) 11
  • Put/Call OI Ratio 0.25
  • Today's Open Interest 480
  • Open Int (30-Day) 453

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate -0.06
  • Number of Estimates 1
  • High Estimate -0.06
  • Low Estimate -0.06
  • Prior Year -0.04
  • Growth Rate Est. (year over year) -50.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.92 +13.02%
on 11/21/24
2.48 -12.50%
on 12/02/24
+0.22 (+11.28%)
since 11/20/24
3-Month
1.41 +53.68%
on 11/07/24
2.55 -14.90%
on 11/12/24
+0.27 (+14.21%)
since 09/20/24
52-Week
1.12 +93.75%
on 08/12/24
2.55 -14.90%
on 11/12/24
+0.66 (+43.71%)
since 12/20/23

Most Recent Stories

More News
MediciNova, Inc. Announces Interim Analysis Results from COMBAT-ALS Trial of MN-166 at International Symposium on ALS/MND

MediciNova presents interim results from COMBAT-ALS trial of MN-166 for ALS at an international symposium.Quiver AI SummaryMediciNova, Inc. announced that interim analysis results from its Phase 2b/3 COMBAT-ALS...

MNOV : 2.17 (+0.46%)
MediciNova Presents Study Update and Interim Analysis of Phase 2/3 Clinical Trial of MN-166 (ibudilast) in ALS (COMBAT-ALS Clinical Trial) at the 35th International Symposium on ALS/MND

MNOV : 2.17 (+0.46%)
MediciNova, Inc. Provides Corporate Update and Highlights Ongoing Clinical Trials for MN166 and Other Programs

MediciNova updates shareholders on clinical trials and strategic collaborations for neurodegenerative diseases and inflammatory conditions.Quiver AI SummaryMediciNova, Inc., a biopharmaceutical company...

MNOV : 2.17 (+0.46%)
MediciNova CEO Yuichi Iwaki Provides Corporate Update in Letter to Stockholders

MNOV : 2.17 (+0.46%)
MediciNova, Inc. Receives Notice of Allowance for Patent on MN-001 Method to Decrease Triglyceride Synthesis in the Liver

MediciNova announces patent allowance for MN-001, a method to reduce liver triglyceride synthesis, aiding metabolic disorder treatments.Quiver AI SummaryMediciNova, Inc. has announced that it received...

MNOV : 2.17 (+0.46%)
MediciNova Receives Notice of Allowance from United States Patent and Trademark Office for New Patent Covering MN-001 for Triglyceride Synthesis in the Liver

MNOV : 2.17 (+0.46%)
MediciNova: Q3 Earnings Snapshot

MediciNova: Q3 Earnings Snapshot

MNOV : 2.17 (+0.46%)
10 Stocks Retailers Are Most Bullish/Bearish About On Tuesday

Earnings have largely impacted sentiment toward stocks that made it to the most bullish and bearish lists on Stocktwits Tuesday.

ALDX : 4.88 (+0.41%)
STIM : 1.3900 (+7.75%)
PGY : 8.95 (+2.76%)
QSI : 1.3000 (+0.78%)
MNOV : 2.17 (+0.46%)
AXSM : 90.73 (+1.10%)
VSAT : 8.79 (+2.45%)
ZS : 187.38 (+2.28%)
BTM : 1.7300 (-4.42%)
RVPH : 1.3400 (-10.67%)
SPY : 591.15 (+1.20%)
XBI : 91.28 (+1.64%)
MediciNova Given Notice of Monetary Damages Due Under Patent Settlement of Sanofi-Novartis

MNOV : 2.17 (+0.46%)
MediciNova Announces Update of Phase 2/3 Clinical Trial of MN-166 (ibudilast) in ALS patients (COMBAT-ALS) at the 2024 Annual NEALS Meeting (Northeast Amyotrophic Lateral Sclerosis Consortium)

MNOV : 2.17 (+0.46%)

Business Summary

MEDICINOVA, INC. is a publicly-traded biopharmaceutical company focused on acquiring and developing novel, small-molecule therapeutics for the treatment of diseases with unmet medical need with a specific focus on the U.S. market. Through strategic alliances primarily with Japanesepharmaceutical companies,...

See More

Key Turning Points

3rd Resistance Point 2.28
2nd Resistance Point 2.25
1st Resistance Point 2.21
Last Price 2.17
1st Support Level 2.14
2nd Support Level 2.11
3rd Support Level 2.07

See More

52-Week High 2.55
Last Price 2.17
Fibonacci 61.8% 2.00
Fibonacci 50% 1.84
Fibonacci 38.2% 1.67
52-Week Low 1.12

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar